أعرض في EDS

Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

التفاصيل البيبلوغرافية
العنوان: Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
المؤلفون: John H. Sampson, Thomas A. Davis, Tibor Keler, Christopher D. Turner, Michael J. Yellin, Jennifer A. Green, Yi He, Laura Vitale, Scott Cruickshank, Maciej M. Mrugala, J. Paul Duic, Lynn S. Ashby, Rimas V. Lukas, Daniela A. Bota, Gordon Li, Louis B. Nabors, Karen L. Fink, David D. Tran, Donald M. O'Rourke, James J. Vredenburgh, Annick Desjardins, David A. Reardon
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5523b850e66966a71fc3a40a27da45
https://doi.org/10.1158/1078-0432.22473939
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....2e5523b850e66966a71fc3a40a27da45
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.